CD44 and posterior fossa ependymoma: Taken together, these results are consistent with the promotion of a microglia-rich microenvironment by posterior fossa ependymoma tumor cells and extend previous bulk transcriptomics results22 by identifying MLCs as the main source for tumor-derived IL-6, CSF1, and CD44 (Supplementary Fig. 3).